Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Carlos Doti, VP US Medical Affairs Oncology at AstraZeneca, shared on LinkedIn:
”As I reflect on another ASH, I’m reminded why this meeting is such a powerful close to the year – where science, collaboration and patient experiences come together to shape the future of hematology.
This year, I participated in two meaningful AstraZeneca events:
Moderating our annual Patient Advocacy Exchange panel with advocacy leaders focused on shared decision-making and patient navigation, discussing how to break down barriers and promote equitable access to care.
Hosting our first-ever AZHemeTalks – a live, pop-up series – at our booth, where I spoke with a clinical trial patient and her doctor about how treatment choices impact daily life.
The video here shows how we brought this activation to life through 4 expert panels focused on the treatment landscape in leukemia, lymphomas and multiple myeloma.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 00:33Overcoming Barriers to Diagnosis and Treatment for Women With Bleeding Disorders – EHC
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents